Browsing: Policymakers
Aimed Alliances Urges Congress to Keep the Current Risk Evaluation and Mitigation Strategies (REMS) Program Intact Report Highlights Need for Policy…
Aimed Alliance has signed on to the Coalition for Accessible Treatments’ letter commenting on the proposed rule, Notice of Benefit…
Aimed Alliance Report Reveals True Drivers of Health Care Costs in the United States America’s Misplaced Anger at Drug Makers:…
Aimed Alliance has signed on to the “I Am Essential” coalition’s letter, urging the United States Department of Health and…
Earlier today, Aimed Alliance’s Director of Public Policy, Stacey L. Worthy, submitted a comment to the U.S. Food and Drug…
Today, Aimed Alliance presented testimony before a joint meeting of the U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug…
Dr. Peter Bach, of New York’s Memorial Sloan Kettering Cancer Center, believes he has found a better way to determine…